RecruitingNCT05635032

Fibrosing ILD Biomarkers That Rule Acceleration

Studying Sarcoidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidade do Porto
Principal Investigator
Helder Novais Bastos, MD, PhD
Universidade do Porto
Intervention
Comprehensive clinical assessment and biological samples collection(other)
Enrollment
150 target
Eligibility
18-80 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Collaborators

Centro Hospitalar De São João, E.P.E. · Instituto de Investigação e Inovação em Saúde (i3S) · Fundação para a Ciência e a Tecnologia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05635032 on ClinicalTrials.gov

Other trials for Sarcoidosis

Additional recruiting or active studies for the same condition.

See all trials for Sarcoidosis →

← Back to all trials